The metabolic syndrome is a socially important disorder of energy utilization and storage, comprising central obesity, hypertriglyceridemia, reduced HDL-cholesterol and raised fasting plasma glucose. It has been estimated that about 20-25 percent of the adult population of the world are affected by this condition. It is a widely known risk factor for the development of cardiovascular diseases and type 2 diabetes. However, it has also been recognized as a factor predisposing to the development of neuropsychiatric disorders, such as depression 1 and anxiety 2 . Obesity is also known to be associated with cognitive impairment in humans. 3 The epidemiological observations have triggered experimental research aiming at proving and elucidating these relationships.
Vitamin K is the family name of structurally related fat-soluble vitamins. Vitamin K1 (phylloquinone) performs the classic functions of vitamin K -it activates vitamin K-dependent clotting factors and anticoagulant proteins. Vitamin K2 is a family of homologues known as menaquinones. It appears that they are mainly acting outside the liver. 4 Extrahepatic actions of menaquinones require higher dietary intake of vitamin K than needed to maintain physiological coagulation status. 5 According to Professor Bruce Ames' "triage theory", the subclinical vitamin K defi cit, without affecting the coagulation status, is widespread and is probably connected to the pathogenesis of diseases associated with aging. 6 Metabolic disorders belong to this type of aging diseases and large epidemiological studies have confi rmed that high dietary vitamin K intake is associated with reduced risk of metabolic syndrome 7 and diabetes type 2 8, 9 . The metabolic effects of vitamin K have been studied in intact rats 10 and in rats with streptozotocin-induced diabetes 11 but not in rats subjected to experimental models of metabolic syndrome.
The effects of vitamin K on the central nervous system have been studied mainly in in vitro conditions. They have shown that vitamin K, based on its antioxidant actions 12, 13 , protects neurons and oligodendrocytes from oxidative damage 14 and have proved that the naphthoquinone ring is responsible for the neuroprotective action 15 . A possible role of vitamin K defi ciency in pathogenesis of neurodegenerative diseases has been suggested. 16 Behavioral effects of vitamin K on rats, either intact or with metabolic syndrome, have not been studied.
In the present study we examined the behavioral effects of vitamin K2 in intact rats and in rats with metabolic syndrome and looked for relationships between these effects and changes in the fasting blood glucose levels caused by the vitamin K2 treatment.
MATERIALS AND METHODS

EXPERIMENTAL ANIMALS
The study included 40 male Wistar rats. The animals were kept at an ambient temperature of 20-25°C, 12-hour light-dark cycle and free access to food and water. The study was approved by the Foods Safety Commission in the Ministry of Agriculture and Foods.
The experimental animals were allocated in 4 groups of 10 rats each, with initial body weight ranging between 220 and 296 g (on the average, 262 g in each group). The duration of the study was 10 weeks. The groups were as follows: group C (control), group K2 (control rats treated with vitamin K2), group MS (rats with metabolic syndrome) and group K2+MS (rats with metabolic syndrome treated with vitamin K2).
DIETS AND TREATMENT
The rats from groups C and K2 were fed a standard rat chow and were given plain water to drink. With each 100 g food consumed, the animals from these groups had a caloric intake of 279 kcal. The rats from groups MS and K2+MS were subjected to a diet-induced metabolic syndrome. 17 They were given a high fat high fructose (HFHF) diet with lard (17%) and fructose (17%) added to the standard rat chow and a 10% fructose solution instead of drinking water. The caloric intake was 405 kcal per 100 g food and 40 kcal per 100 ml water.
Groups K2 and K2+MS were treated with vitamin K2 purchased from Seebio Biotech, Inc., in the form of 1.3% oily solution of menaquinone-7 in sunfl ower oil. Vitamin K2 was administered orally in a dose of 35 mg/kg (0.2 ml oily solution per 100 g body weight) through an intragastral gavage 5 days in a week, from Monday to Friday, for 10 weeks. Since vitamin K2 was dissolved in sunfl ower oil, the rats from C and MS groups received the vehicle, sunfl ower oil, at the same amount and manner.
FASTING BLOOD GLUCOSE DETERMINATION At the end of the study rats were fasted for 4 hours and blood glucose was measured. Blood samples were taken by incision of the distal part of the tail. 18 Blood glucose levels were measured by a glucometer (ACCU-CHEK Performa).
BEHAVIORAL TESTS
The behavioural test were performed after 10 weeks of diet loading and vitamin K2 treatment.
Social interaction test
Social interaction test is often used to measure the level of anxiety. 19 It was performed in uniformly lighted square fi eld (100×100 cm) with surrounding walls 40 cm high to prevent escape. The fi eld was painted white except for 6 mm blue lines that divided the fl oor into 25 equal size squares (20×20 cm). Each rat was tested with an unknown partner with similar weight. Both members of a pair were fed or treated in the same way. The rats were placed simultaneously in the opposite corners of the area. Their behavior was observed in silence for 5 minutes and the time of social interaction was recorded for each rat. The active interactions such as sniffi ng, grooming, following, crawling under or over the partner were scored. The passive contact (sitting or lying with bodies in contact) was not considered as a social interaction time.
Forced swim test
The forced swim test, designed by Porsolt 20 , is a routinely used test to determine the depression-like state of rodents. Each rat was put in a glass cylinder (17 cm diameter and 60 cm height) full with water (25°C) and its behavior was observed for 5 minutes. The water was 30 cm deep so the animals could not touch the bottom with their tails or feet. The immobility time was recorded as a measure of depressive behavior.
Object recognition test
Object recognition test is used as a screening test for working memory. 21 It was performed in a uniformly lighted rectangular area (60×60 cm) surrounded by 40 cm walls. The training session was performed with two identical objects -cubes made of gypsum that were suffi ciently heavy to prevent their moving by the rats. Objects were placed symmetrically. Exploration, defi ned as orienting toward the object from a distance of 1 cm or less, actively sniffi ng or climbing on the object, was measured for 3 minutes. The session with a novel object was performed 5 hours later. Each animal was placed in the area with one of the cubes and the novel object (a gypsum-made pyramid) and was allowed to explore the objects for 3 minutes. The time spent in exploration of the novel object (B) and the old object (A) was recorded. The discrimination ratio B/ (A+B) was calculated. It is the time that a rat spent exploring the novel object relative to the total time of exploration of both objects. The discrimination ratio was used as a measure of recognition memory. 
STATISTICAL ANALYSIS
Results are presented as a mean±SEM. The results from two groups (C and MS; MS and K2+MS) were analyzed with unpaired t test. Association between behavioral results and fasting blood glucose were analyzed by correlation analysis and linear regression. A level of p<0.05 was considered signifi cant. Analyses were performed using GraphPad Prism statistical software.
RESULTS
Fasting blood glucose levels are presented in Fig.  1 . There was no difference between group C and group K2. Dietary manipulated rats (MS group) had a higher blood glucose level: 6.633±0.1054 mmol/L compared to 5.930±0.1375 mmol/L in group C (t=3.991, p=0.0009). In group K2+MS the fasting plasma glucose was 5.617±0.1662 mmol/L (t=5.450, p=0.0001 vs MS).
Results from the behavioral tests are presented in Fig. 2 . In all the tests vitamin K2 caused no changes in the behavior of the rats compared to the control group. Rats from the MS group demonstrated decreased time of social interaction (21.13±1.663 sec vs 37.56±4.482 sec in group C, t=3.273, p=0.0051) -a sign of anxiety-like behavior ( Fig. 2A) . They had also increased immobility time in the forced swim test (219.0±10.20 sec vs 181.9±6.730 sec in group C, t=2.981, p=0.0067), revealing depressionlike behavior (Fig. 2B) . In the object recognition test the discrimination ratio was decreased in the MS group (0.3327±0.03588 vs 0.4455±0.03099 in the C group, t=2.378, p=0.0275), implying memory impairment (Fig. 2C) . Treatment with vitamin K2 counteracted anxiety (social interaction time in the K2+MS group was 40.40±4.700 sec, t=3.511, p=0.0029 vs MS) and depression (immobility time in the K2+MS group was 162.9±13.42 sec, t=3.294, p=0.0040 vs MS) but did not improve memory function of rats subjected to diet manipulation.
The results from the correlation analyses are shown in Fig. 3 . The effect of vitamin K2 was differentially correlated with blood sugar in the 3 behavioral tests. In the social interaction test (Fig.  3A) , there was an inverse correlation between the fasting blood glucose and the time of social interaction when only rats from the C and the MS groups were analyzed (Pearson r=-0.6306, p=0.0088). The inverse correlation was preserved when rats from the K2 and the K2+MS groups were added (Pearson r=-0.4417, p=0.0129). In the forced swim test (Fig.  3B) , no correlation was found between the blood glucose and the immobility time, neither when only vitamin K2 untreated animals were analyzed, nor when all animals were included in analysis. In the object recognition test (Fig. 3C) , an inverse correlation between the fasting blood glucose and the discrimination ratio was found among vitamin K2 untreated rats (C and MS groups -Pearson r=-0.5944, p=0.0152). When vitamin K2-treated rats were added to the analysis (K2 and K2+MS groups), the correlation was lost.
DISCUSSION
The results from the present study suggest that rats with diet-induced metabolic syndrome developed increased anxiety, depression-like behavior and memory impairment. In our previous 17 and present experiments the metabolic syndrome was verifi ed by visceral obesity and biochemical parameters, which also included elevated fasting blood glucose. Vitamin K2 treatment prevented the elevation of fasting blood glucose -a result consistent with fi ndings reported in the literature for humans 22 and diabetic rats 10, 11 . Indeed, our study is the fi rst to show an anti-hyperglycemic effect of vitamin K2 in rats subjected to HFHF diet-induced metabolic syndrome. We also have demonstrated for the fi rst time that vitamin K2 is capable of exerting antianxiety and antidepressant effects.
EFFECTS ON ANXIETY
There is limited evidence of the coexistence of anxiety in metabolic syndrome patients -it seems to be a byproduct of anxiety-depression comorbidity, stress and negative health behaviors. 23 Although moderate level of evidence exists for a positive association between obesity and anxiety disorders, the exact association between these two conditions is not yet clear. 24 The results from experimental studies are quite inconsistent. Both reduced and increased anxiety measures have been found in rodents fed high-caloric diets containing fat, sugars or both. 25 Some of the studies have observed gender-dependent changes in anxiety 26, 27 implying that female rats may react by reduced anxiety to diet-induced metabolic changes. Increased anxiety has been found in streptozotocininduced diabetes in mice. 28 Similarly to Buchenauer 29 and Sousa 30 , we found that feeding rats with diet rich in lard and fructose increased their level of anxiety. Our results further show that anxiety correlated with the fasting blood glucose, implying that metabolic changes might be, at least in part, responsible for the dietary anxiogenic effect. The association between anxiety and blood glucose imbalances is not widely addressed in the literature. Nevertheless, according to a metaanalysis, anxiety determined by diagnostic interviews is highly associated with hyperglycemia in patients with type 1 and type 2 diabetes. 31 An interesting fi nding in our study was that vitamin K2 treatment prevented not only the increase of plasma glucose, but it also antagonized the HFHF diet-induced anxiety. In addition, vitamin K2 treatment preserved the association between hyperglycemia and anxiety. The effect of vitamin K2 on rat anxiety thus seems to be linked with the effect on blood glucose. Moreover, this is the fi rst study to demonstrate an anxiolytic effect of MK-7 in rats with MS, while exerting no effect in intact animals. The two effects observed appear to be at least connected with each other, if not inter-related. Mood disorders and metabolic syndrome have been shown to present overlapping pathophysiology where multiple factors such as insulin and leptin resistance, pro-infl ammatory cytokines, reactive oxygen species, glucocorticoids are involved in a complex interplay in the brain. 32, 33 The results from our study showed that rats subjected to the dietary model of metabolic syndrome displayed increased immobility time in the forced swim test consistent with depression-like behavior. This behavior was antagonized by the treatment with vitamin K2. The score of depression, however, unlike the score of anxiety, did not correlate with blood glucose levels both in untreated rats and in those treated with vitamin K2. We can speculate therefore that the antidepressant effect of vitamin K2 is not directly related to its effects on blood sugar. Rather, it could potentially be due to its antioxidant and anti-infl ammatory actions. Vitamin K1 and K2 have been shown to prevent oxidative injury to developing oligodendrocytes and neurons 14 and vitamin K2 has been found to be the more potent neuroprotective agent in vitro 15 . A recent epidemiological study on the dietary intake of phylloquinone has found a longitudinal reduction effect on pro-infl ammatory markers, related to insulin resistance and diabetes. 34 Thus, it is feasible to relate the observed effect of vitamin K2 on depression in rats with diet-induced metabolic syndrome to its ability to prevent or reduce the impact of infl ammation and oxidative stress on this behavior. EFFECTS ON MEMORY Metabolic syndrome and obesity are known to affect cognition and raise the risk of dementia. 35 In our study we observed a lower discrimination ratio in the animals fed HFHF diet compared to control rats, consistent with other experimental works on cognitive functions. Most authors report on impairments in the spatial memory 36 , which appears to be more sensitive to dietary intervention compared to recognition and other types of non-spatial working memory 37, 38 . In the current study we demonstrated that in rats subjected to HFHF diet for a long enough period of time the recognition memory impairment was correlated with fasting glucose levels, similarly to the fi ndings of Jurdak and Kanarek. 39 The treatment with vitamin K2, however, did not counteract the memory defi cit irrespective of its effect on the fasting blood glucose.
The brain structure mostly involved in memory formation is the hippocampus, and it is mainly responsible for spatial memory. 40 As for the recognition memory, it is the perirhinal cortex that is thought to be involved in object recognition after short retention intervals, while the hippocampus is responsible for the long-term object recognition. 41 Cognitive impairment in diet-induced metabolic disorders has been associated with hippocampal damage, including infl ammation and oxidative stress 36 ; less is known about the postulated biological mechanisms of non-spatial memory defi cits.
The fi nding of ineffi cacy of vitamin K2 to prevent the cognitive impairment in our study was somewhat unexpected, given the antioxidant 14 , neuroprotective 15 , and anti-infl ammatory 34 properties described in the literature. Due to its regulation of sulfotransferase activity and the activity of a growth factor/tyrosine kinase receptor (Gas 6/Axl) in the brain a hypothesis has been proposed that vitamin K defi ciency contributes to the pathogenesis of Alzheimer's disease. 16 Moreover, a recent study among geriatric patients revealed improved cognition associated with higher dietary intake of vitamin K. 42 A possible explanation of the negative results in our experiments would be that this particular test for measuring memory impairment in diet-induced metabolic syndrome is for some reason insensitive to vitamin K2. Alternatively, it might be that the brain structures involved in this type of memory are not particularly affected by oxidative stress and infl ammation through the metabolic disturbances of the model used. 43 
CONCLUSION
The present study has demonstrated that the high-fat high-fructose diet-induced metabolic syndrome in rats is associated with development of behavioral disorders such as anxiety, depression and cognitive impairment. Vitamin K2 treatment prevented the elevation of fasting blood glucose level caused by the dietary manipulation and also the development of anxiety and depression. However, it did not improve the memory defi cit. The effect of vitamin K2 was differentially correlated with blood sugar in the three behavioral tests hence we concluded that the anxiolytic effect of vitamin K2 is probably mediated, at least in part, by its action on blood sugar while the antidepressant effect of vitamin K2 is unrelated to its effect on blood glucose.
